These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15714423)

  • 61. The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials.
    Sheth SH; Larson RJ
    BMC Infect Dis; 2010 Jun; 10():183. PubMed ID: 20573187
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Leptin deficiency: clinical implications and opportunities for therapeutic interventions.
    Blüher S; Shah S; Mantzoros CS
    J Investig Med; 2009 Oct; 57(7):784-8. PubMed ID: 19730134
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Whither recombinant human leptin treatment for HIV-associated lipoatrophy and the metabolic syndrome?
    Mantzoros CS
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1089-91. PubMed ID: 19349474
    [No Abstract]   [Full Text] [Related]  

  • 64. The effects of Thiazolidinediones on metabolic complications and Lipodystrophy in HIV-infected patients.
    Sutinen J
    PPAR Res; 2009; 2009():373524. PubMed ID: 19096512
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
    Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.
    Rosenson RS; Wolff DA; Huskin AL; Helenowski IB; Rademaker AW
    Diabetes Care; 2007 Aug; 30(8):1945-51. PubMed ID: 17483155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.
    Rosenson RS
    Am Heart J; 2008 Mar; 155(3):499.e9-16. PubMed ID: 18294485
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).
    Schindler K; Rieger A; Tura A; Gmeinhardt B; Touzeau-Römer V; Haider D; Pacini G; Ludvik B
    Horm Metab Res; 2009 Jul; 41(7):573-9. PubMed ID: 19322744
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2 x 2 factorial, randomized, double-blinded, placebo-controlled trial.
    Gavrila A; Hsu W; Tsiodras S; Doweiko J; Gautam S; Martin L; Moses AC; Karchmer AW; Mantzoros CS
    Clin Infect Dis; 2005 Mar; 40(5):745-9. PubMed ID: 15714423
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mechanisms and strategies for insulin resistance in acquired immune deficiency syndrome.
    Grinspoon S
    Clin Infect Dis; 2003; 37 Suppl 2():S85-90. PubMed ID: 12942379
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Combination therapy in the management of mixed dyslipidaemia.
    Cannon CP
    J Intern Med; 2008 Apr; 263(4):353-65. PubMed ID: 18324928
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G
    Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Pioglitazone].
    Yokoi H
    Nihon Rinsho; 2011 Sep; 69 Suppl 7():378-89. PubMed ID: 22519020
    [No Abstract]   [Full Text] [Related]  

  • 74. Thiazolidinedione therapy for managing metabolic syndrome.
    Geurin MD; St Anna L
    Am Fam Physician; 2010 Dec; 82(12):1553-4. PubMed ID: 21166377
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.